# Single Dose Escalation Study of CM383 in Healthy Volunteers

> **NCT06412185** · PHASE1 · RECRUITING · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 56 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **BIOLOGICAL:** CM383
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06412185
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06412185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06412185, "Single Dose Escalation Study of CM383 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06412185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*